TSS
UTHR icon

Two Sigma Securities’s United Therapeutics UTHR Stock Holding History

Two Sigma Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
2,726
+2,216
+435% +$1.25M 0.13% 172
2026
Q1 		$302K Buy
+510
New +$254K 0.04% 771
2025
Q4 		– Sell
-2,790
Closed -$1.17M – 2043
2025
Q3 		$1.17M Buy
2,790
+2,046
+275% +$688K 0.17% 136
2025
Q2 		$214K Buy
+744
New +$222K 0.03% 883
2024
Q3 		– Sell
-1,429
Closed -$483K – 3666
2024
Q2 		$455K Buy
1,429
+70
+5% +$18.5K 0.01% 1627
2024
Q1 		$312K Buy
1,359
+272
+25% +$61.4K ﹤0.01% 1930
2023
Q4 		$239K Sell
1,087
-77
-7% -$17.7K ﹤0.01% 2220
2023
Q3 		$263K Buy
+1,164
New +$268K ﹤0.01% 2064
2023
Q2 		– Sell
-1,781
Closed -$394K – 3375
2023
Q1 		$399K Buy
1,781
+1,047
+143% +$258K 0.01% 1430
2022
Q4 		$204K Buy
+734
New +$185K 0.01% 1937
2022
Q3 		– Sell
-3,135
Closed -$739K – 3130
2022
Q2 		$739K Buy
+3,135
New +$637K 0.03% 683
2021
Q4 		– Sell
-1,174
Closed -$217K – 2076
2021
Q3 		$217K Buy
+1,174
New +$231K 0.01% 1192
2019
Q2 		– Sell
-2,349
Closed -$276K – 2438
2019
Q1 		$276K Buy
+2,349
New +$274K ﹤0.01% 1254
2018
Q4 		– Sell
-1,651
Closed -$211K – 2866
2018
Q3 		$211K Buy
+1,651
New +$204K ﹤0.01% 2089
2017
Q3 		– Sell
-2,689
Closed -$349K – 1234
2017
Q2 		$349K Buy
+2,689
New +$335K 0.07% 302
2015
Q4 		– Sell
-1,610
Closed -$211K – 372
2015
Q3 		$211K Buy
+1,610
New +$258K 0.33% 124

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Two Sigma Securities's UTHR Position: Q2 2026 in Review

Two Sigma Securities increased its United Therapeutics (UTHR) stake by 435% in Q2 2026, buying an estimated $1.25M and bringing the position to 2,726 shares worth $1.48M. The position accounts for 0.13% of the portfolio, ranked #172.

Two Sigma Securities first reported a position in UTHR in Q3 2015 and has held it in 16 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Two Sigma Securities held 2,726 shares of United Therapeutics worth $1.48M as of Q2 2026.
  • Two Sigma Securities bought 2,216 United Therapeutics shares in Q2 2026, an estimated $1.25M.
  • United Therapeutics made up 0.13% of Two Sigma Securities's portfolio in Q2 2026, its #172 holding.
  • Two Sigma Securities first reported a position in United Therapeutics in Q3 2015 and has held it in 16 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.